Economic and clinical outcomes of pegfilgrastim via prefilled syringe vs on-body injector: A real-world data analysis

by Campbell, D., Campbell, K., Li, E., McBride, A., Schroader, B., Wang, W.
Published 2021

Economic burden of managing Type 2 diabetes mellitus: Analysis from a Teaching Hospital in Malaysia

by Ahmed, Z., Ismail, A., Kamaruddin, N.A, Suddin, L.S, Sukor, N., Sulong, S.
Published 2017

Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States

by Ewenstein, B., Farahbakhshian, S., Lu, M., Oladapo, A., Wu, Y.
Published 2021

Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: Evidence from a managed care database in the United States

by Bell, C.F, Blauer-Peterson, C., Mao, J.
Published 2021

Medical costs and associated racial/ethnic and sex disparities in erythropoiesis-stimulating agent use: anemia management under the Medicare reimbursement policy

by Cai, B., Kevin Lu, Z., Li, M., Mauldin, P.
Published 2021

The Cost and Cost-utility of Three Public Health HIV Case-finding Strategies: Evidence from Rhode Island, 2012–2014

by Bertrand, T., Chan, P.A, Galárraga, O., Kusi, L., Li, X.C, Marak, T.
Published 2018

Optima TB: A tool to help optimally allocate tuberculosis spending

by Abeysuriya, R., Abou Jaoude, G.J, Abubakar, I., Benedikt, C., Cheikh, N., Fraser-Hurt, N., Gorgens, M., Goscé, L., Haghparast-Bidgoli, H., Hurevich, H., Hussain, A., Jarvis, S., Kedziora, D.J, Kelly, S.L, Kerr, C.C, Klimuk, D., Martin-Hughes, R., Palmer, T., Panovska-Griffiths, J., Roberts, A., Skordis, J., Skrahina, A., Stuart, R.M, Wilson, D.J, Wilson, D.P, Zhao, F.
Published 2021

Mitigating the risk of COVID-19 exposure by transitioning from clinic-based to home-based immune globulin infusion

by Abdelghany, O., Barbarotta, L., Bocchetta, N., Clinchy-Jarmoszko, V., Foss, F., Huntington, S., Isufi, I., Perreault, S., Schiffer, M., Seropian, S.
Published 2021

Household expenditure for dental care in low and middle income countries

by Bernabé, E., Masood, M., Sheiham, A.
Published 2015

Prevalence of statin utilization and adherence among privately insured subjects in the Commonwealth of Puerto Rico

by Hernández-Muñoz, J.J, Kamdar, C.R, Wong, E.S
Published 2021

Comparison of COPD health care utilization and associated costs across patients treated with LAMA+LABA fixed-dose therapies

by Bengtson, L.G.S, Chastek, B., Palli, S.R, Xie, B.
Published 2021

Wealth and cardiovascular health: A cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income co...

by Alhabib, K.F, Avezum, A., Jr, Bahonar, A., Balabanova, D., Chifamba, J., Chow, C.K, Corsi, D.J, Dagenais, G.R, Diaz, R., Gupta, R., Iqbal, R., Ismail, N., Kaur, M., Khatib, R., Kruger, A., Kruger, I.M, Lanas, F., Lopez-Jaramillo, P., McKee, M., Minfan, F., Mohan, V., Mony, P.K, Oguz, A., Palafox, B., Palileo-Villanueva, L.M, Perel, P., Poirier, P., Rangarajan, S., Rensheng, L., Rosengren, A., Soman, B., Stuckler, D., Subramanian, S.V, Teo, K., Tsolekile, L.P, Wielgosz, A., Yaguang, P., Yeates, K., Yongzhen, M., Yusoff, K., Yusuf, R., Yusuf, S., Yusufali, A., Zatońska, K.
Published 2016

Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy

by Palli, S.R, Shaikh, A., Willey, V.J, Zhou, S.
Published 2021

Health care resource utilization and cost of severe hypoglycemia treatment in insulin-treated patients with diabetes in the United States

by Ali, A.K, Bajpai, S., Chinthammit, C., Haynes, G., Liu, D., Mitchell, B., Syring, K., Wong-Jacobson, S.
Published 2021

Cost-effectiveness of once-daily vs twice-daily tacrolimus among Hispanic and Black kidney transplant recipients

by Grizzle, A.J, Hurwitz, J.T, Malone, D.C, Tyler, C.S, Zapata, L.V
Published 2021

Health care resource utilization and costs of recurrent Clostridioides difficile infection in the elderly: A real-world claims analysis

by Boules, M., Feuerstadt, P., Nelson, W.W, Parente, A., Scott, T.A, Teigland, C., Unni, S.
Published 2021

Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States

by Chatterjee, A., Davids, M.S, Manzoor, B.S, Qendri, V., Ravelo, A., Sail, K., Shapouri, S., van de Wetering, G.
Published 2021

Direct medical costs of obesity in the United States and the most populous states

by Biener, A., Cawley, J., Ding, Y., Gabriel Smolarz, N.B, Meyerhoefer, C., Ramasamy, A., Zvenyach, T.
Published 2021

Primary care provider payment models and adherence to anticoagulation in patients with atrial fibrillation

by Gellad, W.F, Guo, J., Hernandez, I., Liang, Q., Newman, T.V, Yang, L.
Published 2021

Cost-effectiveness of gilteritinib for relapsed/ refractory FLT3mut+ acute myeloid leukemia

by Garnham, A., Pandya, B.J, Qi, C.Z, Shah, M.V, Yang, H., Zeidan, A.M
Published 2021